MMSI logo

Merit Medical Systems, Inc. Stock Price

NasdaqGS:MMSI Community·US$5.0b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

MMSI Share Price Performance

US$84.88
-20.15 (-19.18%)
US$103.55
Fair Value
US$84.88
-20.15 (-19.18%)
18.2% undervalued intrinsic discount
US$103.75
Fair Value
Price US$84.88
AnalystConsensusTarget US$103.75

MMSI Community Narratives

AnalystConsensusTarget·
Fair Value US$103.55 18.0% undervalued intrinsic discount

Global Aging And Healthcare Demand Will Expand Medical Procedures

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Updated Narratives

MMSI logo

Global Aging And Healthcare Demand Will Expand Medical Procedures

Fair Value: US$103.55 18.0% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with limited growth.

0 Risks
2 Rewards

Merit Medical Systems, Inc. Key Details

US$1.5b

Revenue

US$761.2m

Cost of Revenue

US$715.9m

Gross Profit

US$597.5m

Other Expenses

US$118.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
2.00
48.47%
8.02%
47.9%
View Full Analysis

About MMSI

Founded
1987
Employees
7400
CEO
Martha Aronson
WebsiteView website
www.merit.com

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Recent MMSI News & Updates

Recent updates

No updates